Manulife (Manufacturers Life Insurance)’s The Oncology Institute TOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$67.2K Buy
21,894
+63
+0.3% +$193 ﹤0.01% 2696
2025
Q4
$77.7K Buy
21,831
+1,037
+5% +$3.85K ﹤0.01% 2757
2025
Q3
$72.6K Sell
20,794
-97
-0.5% -$332 ﹤0.01% 2837
2025
Q2
$42.8K Buy
+20,891
New +$52.2K ﹤0.01% 2899

Other funds holding TOI

Manulife (Manufacturers Life Insurance)'s TOI Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) increased its The Oncology Institute (TOI) stake by 0.29% in Q1 2026, buying an estimated $193 and bringing the position to 21,894 shares worth $67.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2696.

Manulife (Manufacturers Life Insurance) first reported a position in TOI in Q2 2025 and has held it in 4 quarters since. The position peaked at $77.7K in Q4 2025. 115 funds tracked by Wall St. Rank hold TOI as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 21,894 shares of The Oncology Institute worth $67.2K as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) bought 63 The Oncology Institute shares in Q1 2026, an estimated $193.
  • The Oncology Institute made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2696 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in The Oncology Institute in Q2 2025 and has held it in 4 quarters since.
  • Manulife (Manufacturers Life Insurance)'s The Oncology Institute position peaked at $77.7K in Q4 2025.
  • 115 funds tracked by Wall St. Rank held The Oncology Institute as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.